Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|October 28, 2015
Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese SubjectsJiuhong Zha, Prajakta S Badri, Bifeng Ding, et al.
Critical Care (London, England)|November 15, 2012
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumoniaMarin H Kollef, Jean Chastre, Marc Clavel, et al.
The Pediatric Infectious Disease Journal|July 31, 2015
Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and PneumoniaChristopher R Cannavino, Bibiana Castaneda-Ruiz, Rebecca Redman, et al.
The Journal of Community and Supportive Oncology|February 13, 2016
Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimensTeresa S Finnegan, Neal H Bhatt, Joseph N Shaughnessy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking StatusMark J Amsbaugh, Mehran Yusuf, Elizabeth Cash, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy menIolanda Cirillo, Geert Mannens, Cor Janssen, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Association of Macrophage Migration Inhibitory Factor (MIF) with Therapy Response and Clinical Outcomes in HPV-Related Head and Neck Squamous Cell Carcinoma: A Preliminary ReportJanki Naidugari, Shruti Wadhwa, Benjamin Xie, et al.
Advances in Therapy|May 25, 2017
Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese PatientsKen Sato, Kazuaki Chayama, Katia Alves, et al.
Head & Neck|April 9, 2014
Impact of transcutaneous neuromuscular electrical stimulation on dysphagia in patients with head and neck cancer treated with definitive chemoradiationAashish D Bhatt, Nicole Goodwin, Elizabeth Cash, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and OmbitasvirPreethi Krishnan, Gretja Schnell, Rakesh Tripathi, et al.
Pageof 5